186 related articles for article (PubMed ID: 33441593)
1. Early β adrenoceptor dependent time window for fear memory persistence in APPswe/PS1dE9 mice.
Karunakaran S
Sci Rep; 2021 Jan; 11(1):870. PubMed ID: 33441593
[TBL] [Abstract][Full Text] [Related]
2. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
3. Early life stress amplifies fear responses and hippocampal synaptic potentiation in the APPswe/PS1dE9 Alzheimer mouse model.
Lesuis SL; Lucassen PJ; Krugers HJ
Neuroscience; 2021 Feb; 454():151-161. PubMed ID: 31302265
[TBL] [Abstract][Full Text] [Related]
4. Locomotor activity, emotionality, sensori-motor gating, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
O'Leary TP; Hussin AT; Gunn RK; Brown RE
Brain Res Bull; 2018 Jun; 140():347-354. PubMed ID: 29870778
[TBL] [Abstract][Full Text] [Related]
5. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
O'Leary TP; Brown RE
Behav Brain Res; 2009 Jul; 201(1):120-7. PubMed ID: 19428625
[TBL] [Abstract][Full Text] [Related]
6. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
[TBL] [Abstract][Full Text] [Related]
7. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
Fu L; Sun Y; Guo Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
Curr Alzheimer Res; 2018; 15(11):1053-1061. PubMed ID: 29984654
[TBL] [Abstract][Full Text] [Related]
8. Banxia Xiexin decoction ameliorated cognition via the regulation of insulin pathways and glucose transporters in the hippocampus of APPswe/PS1dE9 mice.
Chen F; He Y; Wang P; Wei P; Feng H; Rao Y; Shi J; Tian J
Int J Immunopathol Pharmacol; 2018; 32():2058738418780066. PubMed ID: 29873261
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Stover KR; Brown RE
Behav Brain Res; 2012 May; 231(1):75-85. PubMed ID: 22409975
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
Wang D; Liu X; Liu Y; Li S; Wang C
J Alzheimers Dis; 2017; 59(4):1255-1267. PubMed ID: 28731433
[TBL] [Abstract][Full Text] [Related]
11. Both male and female APPswe/PSEN1dE9 mice are impaired in spatial memory and cognitive flexibility at 9 months of age.
Hulshof LA; Frajmund LA; van Nuijs D; van der Heijden DCN; Middeldorp J; Hol EM
Neurobiol Aging; 2022 May; 113():28-38. PubMed ID: 35294867
[TBL] [Abstract][Full Text] [Related]
12. Deficit in long-term contextual fear memory induced by blockade of beta-adrenoceptors in hippocampal CA1 region.
Ji JZ; Wang XM; Li BM
Eur J Neurosci; 2003 May; 17(9):1947-52. PubMed ID: 12752794
[TBL] [Abstract][Full Text] [Related]
13. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
Bonardi C; de Pulford F; Jennings D; Pardon MC
Behav Brain Res; 2011 Sep; 222(1):89-97. PubMed ID: 21440575
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
[TBL] [Abstract][Full Text] [Related]
15. Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain.
Yue X; Zhou Y; Qiao M; Zhao X; Huang X; Zhao T; Cheng X; Fan M; Zhao Y; Chen R; Zhu L
Alzheimers Res Ther; 2021 Nov; 13(1):194. PubMed ID: 34844651
[TBL] [Abstract][Full Text] [Related]
16. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer's Disease.
Petrov D; Luque M; Pedrós I; Ettcheto M; Abad S; Pallàs M; Verdaguer E; Auladell C; Folch J; Camins A
Mol Neurobiol; 2016 Nov; 53(9):6183-6193. PubMed ID: 26558630
[TBL] [Abstract][Full Text] [Related]
18. Effects of curcumin on synapses in APPswe/PS1dE9 mice.
He Y; Wang P; Wei P; Feng H; Ren Y; Yang J; Rao Y; Shi J; Tian J
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):217-25. PubMed ID: 26957323
[TBL] [Abstract][Full Text] [Related]
19. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
20. Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer's disease.
Wang D; Li X; Gao K; Lu D; Zhang X; Ma C; Ye F; Zhang L
Pharmacol Biochem Behav; 2013 Jun; 107():48-57. PubMed ID: 23541490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
